Innovative healthcare interventions for non-communicable diseases[E8]

From the notice

Call: Cluster 1 - Health (Two stage - 2027). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: Researchers, developers and clinical practitioners have access to state-of-the-art knowledge, data, technologies, tools, methods, best practices, and trainings to develop innovative healthcare interventions aimed at reducing burden of the following specific Non-Communicable Diseases (NCDs): cardiovascular diseases, diabetes, chronic respiratory diseases or chronic kidney diseases. Scientific and clinical communities can use innovative healthcare interventions to generate meaningful advances in clinical practice and care for patients with NCDs following validation in late-stage clinical trials. Scientific and clinical communities make wide use of relevant databases and/or integrate them with existing infrastructures for storage and sharing of collected data according to FAIR [1] principles, thereby encouraging further use of the data. Policymakers, scientific and clinical communities, developers, patient organisations, regulators, and other relevant bodies are informed of the research advances made and the requirements for a widespread implementation of the innovative therapeutic interventions and complementary approaches. …[E3]

• Open toUniversities and research. Tagged by SLETOR from the listing's own words.
• ConditionEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]

• RiskThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
• UnknownWe read the funder's listing, not the full guidance or application forms.

1. Bidding opened · 29 Oct 2026, 07:41 UTC

   The funder published the call with a future closing date.

   Changed: status, notice type, published at (source record Innovative healthcare interventions for non-communicable diseases (ID HORIZON-HLTH-2027-02-DISEASE-01-two-stage))

2. First seen · 28 Oct 2026, 21:22 UTC

   The funder announced the call. Applications have not opened yet.

   Source record: Innovative healthcare interventions for non-communicable diseases (ID HORIZON-HLTH-2027-02-DISEASE-01-two-stage)

Every fact on this page comes from the funder's listing. Each entry shows the record and the field it was read from.

1. E1

   The funder is European Commission.

   From Innovative healthcare interventions for non-communicable diseases (ID HORIZON-HLTH-2027-02-DISEASE-01-two-stage), field /metadata/type/0, read 29 Oct 2026, 07:41 UTC · source ↗ (opens in a new tab)

2. E2

   Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).

   “2027-02-17T00:00:00.000+0000”

   From Innovative healthcare interventions for non-communicable diseases (ID HORIZON-HLTH-2027-02-DISEASE-01-two-stage), field /metadata/deadlineDate/0, read 29 Oct 2026, 07:41 UTC · source ↗ (opens in a new tab)

3. E3

   The buyer describes the requirement in the notice.

   “Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed…”

   From Innovative healthcare interventions for non-communicable diseases (ID HORIZON-HLTH-2027-02-DISEASE-01-two-stage), field /metadata/descriptionByte/0, read 29 Oct 2026, 07:41 UTC · source ↗ (opens in a new tab)

4. E4

   EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.

   “EU call topic”

   From Innovative healthcare interventions for non-communicable diseases (ID HORIZON-HLTH-2027-02-DISEASE-01-two-stage), field /metadata/type/0, read 29 Oct 2026, 07:41 UTC · source ↗ (opens in a new tab)

5. E5

   This is an EU call for proposals.

   “31094502”

   From Innovative healthcare interventions for non-communicable diseases (ID HORIZON-HLTH-2027-02-DISEASE-01-two-stage), field /metadata/status/0, read 29 Oct 2026, 07:41 UTC · source ↗ (opens in a new tab)

6. E6

   Applications open on 29 Oct 2026.

   “2026-10-29T00:00:00.000+0000”

   From Innovative healthcare interventions for non-communicable diseases (ID HORIZON-HLTH-2027-02-DISEASE-01-two-stage), field /metadata/startDate/0, read 29 Oct 2026, 07:41 UTC · source ↗ (opens in a new tab)

7. E7

   The Funding & Tenders Portal gives the status as open for submission.

   From Innovative healthcare interventions for non-communicable diseases (ID HORIZON-HLTH-2027-02-DISEASE-01-two-stage), field /metadata/status/0, read 29 Oct 2026, 07:41 UTC · source ↗ (opens in a new tab)

8. E8

   The notice is titled "Innovative healthcare interventions for non-communicable diseases".

   From Innovative healthcare interventions for non-communicable diseases (ID HORIZON-HLTH-2027-02-DISEASE-01-two-stage), field /metadata/title/0, read 29 Oct 2026, 07:41 UTC · source ↗ (opens in a new tab)

9. E9

   The EU contribution per grant is up to EUR 10,000,000 (from EUR 5,000,000).

   From Innovative healthcare interventions for non-communicable diseases (ID HORIZON-HLTH-2027-02-DISEASE-01-two-stage), field /metadata/budgetOverview/0, read 29 Oct 2026, 07:41 UTC · source ↗ (opens in a new tab)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Data licence: Creative Commons Attribution 4.0 (European Commission) ↗ (opens in a new tab). Personal contact details in notices are not stored or shown.